Association Between Transthoracic Echocardiography Appropriateness and Echocardiographic Findings.


Journal

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography
ISSN: 1097-6795
Titre abrégé: J Am Soc Echocardiogr
Pays: United States
ID NLM: 8801388

Informations de publication

Date de publication:
05 2019
Historique:
received: 26 09 2018
pubmed: 9 3 2019
medline: 11 11 2020
entrez: 9 3 2019
Statut: ppublish

Résumé

The association between appropriate use criteria and echocardiographic findings in patients with chronic cardiovascular diseases is unknown. As a substudy of the Echo WISELY (Will Inappropriate Scenarios for Echocardiography Lessen Significantly) trial, 9,230 transthoracic echocardiographic (TTE) examinations from six Ontario academic hospitals were linked to a registry of echocardiographic findings. The TTE studies were rated appropriate), rarely appropriate, or may be appropriate according to the 2011 appropriate use criteria. TTE findings of appropriately ordered examinations were compared with those of rarely appropriate examinations for specific disease subsets, including heart failure and valvular heart disease. There were 7,574, 1,087, and 569 TTE examinations ordered for appropriate, rarely appropriate, and may be appropriate indications, and of the 7,574 appropriate studies, 6,399 were ordered for specific indications and 1,175 for general indications. TTE examinations ordered for general indications had lower rates of left ventricular dysfunction (19.6% vs 9.1%, P < .001) and moderate to severe aortic stenosis (15.5% vs 2.6%, P < .001). Of the 2,395 TTE examinations ordered for patients with heart failure, appropriately ordered studies were more likely to result in left ventricular segmental abnormality (37.0% vs 24.9%, P = .012) but similar rates of right ventricular dilatation (15.4% vs 14.7%, P = .79), right ventricular dysfunction (14.8% vs 11.3%, P = .22), and moderate to severe mitral regurgitation (12.1% vs 9.2%, P = .35). Of the 2,859 studies ordered to assess valvular heart disease, appropriately ordered studies were significantly more likely to find moderate to severe valvular pathology, including aortic stenosis (30.4% vs 24.6%, P = .008), aortic regurgitation (8.9% vs 1.6%, P < .001), mitral stenosis (6.7% vs 3.1%, P = .002), and mitral regurgitation (16.1% vs 6.1%, P < .001), but similar rates of tricuspid regurgitation (11.2% vs 13.0%, P = .60). Overall, appropriately ordered TTE examinations for heart failure and valvular heart disease were significantly more likely to have abnormal findings than rarely appropriate examinations. TTE studies ordered for general indications had fewer, although still a significant proportion, of abnormalities compared with studies ordered for specific indications.

Sections du résumé

BACKGROUND
The association between appropriate use criteria and echocardiographic findings in patients with chronic cardiovascular diseases is unknown.
METHODS
As a substudy of the Echo WISELY (Will Inappropriate Scenarios for Echocardiography Lessen Significantly) trial, 9,230 transthoracic echocardiographic (TTE) examinations from six Ontario academic hospitals were linked to a registry of echocardiographic findings. The TTE studies were rated appropriate), rarely appropriate, or may be appropriate according to the 2011 appropriate use criteria. TTE findings of appropriately ordered examinations were compared with those of rarely appropriate examinations for specific disease subsets, including heart failure and valvular heart disease.
RESULTS
There were 7,574, 1,087, and 569 TTE examinations ordered for appropriate, rarely appropriate, and may be appropriate indications, and of the 7,574 appropriate studies, 6,399 were ordered for specific indications and 1,175 for general indications. TTE examinations ordered for general indications had lower rates of left ventricular dysfunction (19.6% vs 9.1%, P < .001) and moderate to severe aortic stenosis (15.5% vs 2.6%, P < .001). Of the 2,395 TTE examinations ordered for patients with heart failure, appropriately ordered studies were more likely to result in left ventricular segmental abnormality (37.0% vs 24.9%, P = .012) but similar rates of right ventricular dilatation (15.4% vs 14.7%, P = .79), right ventricular dysfunction (14.8% vs 11.3%, P = .22), and moderate to severe mitral regurgitation (12.1% vs 9.2%, P = .35). Of the 2,859 studies ordered to assess valvular heart disease, appropriately ordered studies were significantly more likely to find moderate to severe valvular pathology, including aortic stenosis (30.4% vs 24.6%, P = .008), aortic regurgitation (8.9% vs 1.6%, P < .001), mitral stenosis (6.7% vs 3.1%, P = .002), and mitral regurgitation (16.1% vs 6.1%, P < .001), but similar rates of tricuspid regurgitation (11.2% vs 13.0%, P = .60).
CONCLUSIONS
Overall, appropriately ordered TTE examinations for heart failure and valvular heart disease were significantly more likely to have abnormal findings than rarely appropriate examinations. TTE studies ordered for general indications had fewer, although still a significant proportion, of abnormalities compared with studies ordered for specific indications.

Identifiants

pubmed: 30846322
pii: S0894-7317(19)30004-5
doi: 10.1016/j.echo.2019.01.004
pii:
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

667-673.e4

Informations de copyright

Copyright © 2019 American Society of Echocardiography. Published by Elsevier Inc. All rights reserved.

Auteurs

Tamryn K Law (TK)

Women's College Hospital, Toronto, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada.

Zachary Bouck (Z)

Women's College Hospital, Toronto, Ontario, Canada.

X Cindy Yin (XC)

Women's College Hospital, Toronto, Ontario, Canada.

David Dudzinski (D)

Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts.

Dorothy Myers (D)

Applied Health Research Centre, Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, Ontario, Canada.

Gillian C Nesbitt (GC)

Cardiology Division, Mount Sinai Hospital, Toronto, Ontario, Canada.

Jeremy Edwards (J)

Echocardiogram and Vascular Lab, St. Michael's Hospital, Toronto, Ontario, Canada.

Kibar Yared (K)

The Scarborough Hospital, Scarborough, Ontario, Canada.

Brian Wong (B)

Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

Mark Hansen (M)

Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

Adina Weinerman (A)

Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

Steven Shadowitz (S)

Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

Michael Farkouh (M)

Applied Health Research Centre, Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, Ontario, Canada; Cardiology Division, Mount Sinai Hospital, Toronto, Ontario, Canada; Peter Munk Cardiac Centre of the University Health Network, Toronto, Ontario, Canada.

Paaladinesh Thavendiranathan (P)

Peter Munk Cardiac Centre of the University Health Network, Toronto, Ontario, Canada.

Jacob Udell (J)

Women's College Hospital, Toronto, Ontario, Canada; Peter Munk Cardiac Centre of the University Health Network, Toronto, Ontario, Canada.

Amer Johri (A)

Queen's University, Kingston, Ontario, Canada.

Chi-Ming Chow (CM)

Echocardiogram and Vascular Lab, St. Michael's Hospital, Toronto, Ontario, Canada.

Harry Rakowski (H)

Peter Munk Cardiac Centre of the University Health Network, Toronto, Ontario, Canada.

Michael H Picard (MH)

Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts.

Rory B Weiner (RB)

Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts.

R Sacha Bhatia (RS)

Women's College Hospital, Toronto, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada. Electronic address: sacha.bhatia@wchospital.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH